Invasive pneumococcal disease: From a tertiary care hospital in the post-vaccine era
A breakthrough infection occurring with 13-valent pneumococcal conjugate vaccine (PCV13) in Turkey are previously described. A breakthrough infection is defined as IPD in a child who had received ≥ 1 PCV-7 or PCV-13 and for which the pneumococcal isolate was a vaccine serotype. During one year perio...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2017-04-01
|
| Series: | Human Vaccines & Immunotherapeutics |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1080/21645515.2016.1256519 |
| _version_ | 1797674527370510336 |
|---|---|
| author | Sevgen Tanır Basaranoglu Eda Karadag Oncel Kubra Aykac Yasemin Ozsurekci Ali Bülent Cengiz Ates Kara Mehmet Ceyhan |
| author_facet | Sevgen Tanır Basaranoglu Eda Karadag Oncel Kubra Aykac Yasemin Ozsurekci Ali Bülent Cengiz Ates Kara Mehmet Ceyhan |
| author_sort | Sevgen Tanır Basaranoglu |
| collection | DOAJ |
| description | A breakthrough infection occurring with 13-valent pneumococcal conjugate vaccine (PCV13) in Turkey are previously described. A breakthrough infection is defined as IPD in a child who had received ≥ 1 PCV-7 or PCV-13 and for which the pneumococcal isolate was a vaccine serotype. During one year period, among 6 patients with invasive pneumococcal infection, 2 patients were considered to have a vaccine failure with serotype 19F. Antibiotic resistance results were remarkable; macrolide resistance were observed in all strains except one, and high and intermediate penicillin resistance were determined in 2 strains. |
| first_indexed | 2024-03-11T22:01:20Z |
| format | Article |
| id | doaj.art-111b30ea0dbf494b8e9c1fc36cf4ecc8 |
| institution | Directory Open Access Journal |
| issn | 2164-5515 2164-554X |
| language | English |
| last_indexed | 2024-03-11T22:01:20Z |
| publishDate | 2017-04-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Human Vaccines & Immunotherapeutics |
| spelling | doaj.art-111b30ea0dbf494b8e9c1fc36cf4ecc82023-09-25T11:00:55ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2017-04-0113496296410.1080/21645515.2016.12565191256519Invasive pneumococcal disease: From a tertiary care hospital in the post-vaccine eraSevgen Tanır Basaranoglu0Eda Karadag Oncel1Kubra Aykac2Yasemin Ozsurekci3Ali Bülent Cengiz4Ates Kara5Mehmet Ceyhan6Hacettepe University Faculty of MedicineHacettepe University Faculty of MedicineHacettepe University Faculty of MedicineHacettepe University Faculty of MedicineHacettepe University Faculty of MedicineHacettepe University Faculty of MedicineHacettepe University Faculty of MedicineA breakthrough infection occurring with 13-valent pneumococcal conjugate vaccine (PCV13) in Turkey are previously described. A breakthrough infection is defined as IPD in a child who had received ≥ 1 PCV-7 or PCV-13 and for which the pneumococcal isolate was a vaccine serotype. During one year period, among 6 patients with invasive pneumococcal infection, 2 patients were considered to have a vaccine failure with serotype 19F. Antibiotic resistance results were remarkable; macrolide resistance were observed in all strains except one, and high and intermediate penicillin resistance were determined in 2 strains.http://dx.doi.org/10.1080/21645515.2016.1256519antibiotic resistancebreakthrough infectioninvasive pneumococcus diseasesurveillancestreptococcus pneumoniaevaccinationvaccine failure |
| spellingShingle | Sevgen Tanır Basaranoglu Eda Karadag Oncel Kubra Aykac Yasemin Ozsurekci Ali Bülent Cengiz Ates Kara Mehmet Ceyhan Invasive pneumococcal disease: From a tertiary care hospital in the post-vaccine era Human Vaccines & Immunotherapeutics antibiotic resistance breakthrough infection invasive pneumococcus disease surveillance streptococcus pneumoniae vaccination vaccine failure |
| title | Invasive pneumococcal disease: From a tertiary care hospital in the post-vaccine era |
| title_full | Invasive pneumococcal disease: From a tertiary care hospital in the post-vaccine era |
| title_fullStr | Invasive pneumococcal disease: From a tertiary care hospital in the post-vaccine era |
| title_full_unstemmed | Invasive pneumococcal disease: From a tertiary care hospital in the post-vaccine era |
| title_short | Invasive pneumococcal disease: From a tertiary care hospital in the post-vaccine era |
| title_sort | invasive pneumococcal disease from a tertiary care hospital in the post vaccine era |
| topic | antibiotic resistance breakthrough infection invasive pneumococcus disease surveillance streptococcus pneumoniae vaccination vaccine failure |
| url | http://dx.doi.org/10.1080/21645515.2016.1256519 |
| work_keys_str_mv | AT sevgentanırbasaranoglu invasivepneumococcaldiseasefromatertiarycarehospitalinthepostvaccineera AT edakaradagoncel invasivepneumococcaldiseasefromatertiarycarehospitalinthepostvaccineera AT kubraaykac invasivepneumococcaldiseasefromatertiarycarehospitalinthepostvaccineera AT yaseminozsurekci invasivepneumococcaldiseasefromatertiarycarehospitalinthepostvaccineera AT alibulentcengiz invasivepneumococcaldiseasefromatertiarycarehospitalinthepostvaccineera AT ateskara invasivepneumococcaldiseasefromatertiarycarehospitalinthepostvaccineera AT mehmetceyhan invasivepneumococcaldiseasefromatertiarycarehospitalinthepostvaccineera |